Dupilumab-associated facial erythema successfully treated with oral ivermectin
Keywords:
dupilumab, facial dermatitis, ; atopic dermatitis, ivermectinReferences
Zhu GA, Chen JK, Chiou A, et al. Assessment of the Development of New Regional Dermatoses in Patients Treated for Atopic Dermatitis With Dupilumab. JAMA Dermatol 2019; 155:850–2.
Jaros J, Hendricks AJ, Shi VY, Lio PA. A Practical Approach to Recalcitrant Face and Neck Dermatitis in Atopic Dermatitis. Dermat Contact Atopic Occup Drug 2020; 31:169–77.
Jo CE, Finstad A, Georgakopoulos JR, et al. Facial and neck erythema associated with dupilumab treatment: A systematic review. J Am Acad Dermatol 2021; 84:1339–47.
Okiyama N, Nakamura Y, Ishitsuka Y, et al. Successful topical treatment with ketoconazole for facial rashes refractory to dupilumab in patients with atopic dermatitis: case reports. J Eur Acad Dermatol Venereol JEADV 2020; 34:e474–6.
Gao DX, Song S, Kahn JS, et al. Treatment of patients experiencing dupilumab facial redness with itraconazole and fluconazole: A single-institutional, retrospective medical record review. J Am Acad Dermatol 2021; :S0190-9622(21)00627-7.
Published
Issue
Section
License
Copyright (c) 2022 Javier Gil-Lianes, Daniel Morgado-Carrasco
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
